Dai Nippon Printing Co., Ltd. (DNP) will launch a new research and development base at the Indian Institute of Technology Hyderabad (IIT Hyderabad) in April 2026, becoming its second overseas R&D hub after the Netherlands. The center will focus on joint research in mobility – especially wireless power systems for electric vehicles – and in medical healthcare, including advanced synthesis routes for active pharmaceutical ingredients
Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) has announced plans to establish a new research and development base in Telangana, India, as part of its global R&D strategy. Scheduled to open in April 2026, this facility will be DNP’s second overseas R&D center, following the one set up in the Netherlands in September 2025. The Indian base will operate within the Technology Research Park (TRP) on the campus of the Indian Institute of Technology Hyderabad (IIT Hyderabad), a leading science and engineering university in India. By embedding its R&D operations within the university’s innovation ecosystem, DNP aims to accelerate the development and real‑world deployment of new technologies.
The collaboration will initially center on two strategic domains: mobility and medical healthcare. In mobility, DNP will work with IIT Hyderabad on wireless power supply systems for electric vehicles (EVs). DNP already holds the world’s largest share in battery pouch materials for EV lithium‑ion batteries and is actively developing technologies for next‑generation mobility. At the Hyderabad base, the company will leverage its sheet‑type coil technology to design, refine, and commercialize wireless EV charging systems, targeting the era of autonomous driving and advanced urban mobility.
In the medical healthcare space, DNP will pursue joint research on efficient synthesis routes for active pharmaceutical ingredients (APIs). Drawing on the expertise of DNP Fine Chemicals Utsunomiya Co., Ltd., a DNP Group company, the project will cover the full development chain- from route design and prototyping to process evaluation and scale‑up for mass production. The goal is to create high‑yield, environmentally sound API manufacturing processes, paving the way for cost‑effective and reliable drug supply chains.
Going forward, DNP intends to position India as one of its global API development hubs, with the Hyderabad base serving as a key node for research, commercialization, and market entry -not only in India but also in regions such as Africa. By combining IIT Hyderabad’s strengths in talent, academic research, and innovation with DNP’s competencies in microfabrication, precision coating, and industrial process development, both partners seek to shorten the path from laboratory concept to market‑ready solution.
Founded in 1876, DNP has evolved into a global company that uses print‑based and advanced manufacturing technologies to create new business opportunities while emphasizing environmental sustainability. IIT Hyderabad, established in 2008, is ranked 7th among engineering institutes in the NIRF‑2025 rankings and 6th in the Innovation category, reflecting its strong research and technology‑development ecosystem.
For more information about IIT Hyderabad, visit: https://www.iith.ac.in/.